The document provides an overview of the pharmacotherapy management of anxiety disorders, detailing both short-term and long-term treatment goals. It lists various medications with anxiolytic properties, such as benzodiazepines, SSRIs, and other classes, alongside their efficacy and profiles. It also discusses the future need for sophisticated anxiolytics that are non-sedating, safe, and affordable.